<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR52">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ansell</surname>
    <given-names>SM</given-names>
   </name>
   <name>
    <surname>Lesokhin</surname>
    <given-names>AM</given-names>
   </name>
   <name>
    <surname>Borrello</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Halwani</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Scott</surname>
    <given-names>EC</given-names>
   </name>
   <name>
    <surname>Gutierrez</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma</article-title>
  <source>N Engl J Med</source>
  <year>2015</year>
  <volume>372</volume>
  <fpage>311</fpage>
  <lpage>319</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1411087</pub-id>
  <pub-id pub-id-type="pmid">25482239</pub-id>
 </element-citation>
</ref>
